-- Justin Adams, Director of Technology Strategy, BP
-- Jeff Andrews, Partner, Atlas Ventures
-- Richard Chleboski, Vice President, Worldwide Expansion, Evergreen
Solar
-- Dennis Costello, Partner, Braemer Energy Ventures
-- William Davis, President and CEO, Ze-gen
-- John Doyle, Vice President, Projects, Verenium Corporation
-- Jim Gordon, President, Cape Wind
-- Christina Lampe-Onnerud, Founder and CEO, Boston-Power, Inc.
-- Andrew Perlman, President and CEO, Great Point Energy
-- Peter Rothstein, Entrepreneur-in-Residence, Flagship Ventures
Healthcare and Life Sciences Track
-- Noubar Afeyan, Ph.D., Managing Partner and CEO, Flagship Ventures
-- John Brennan, Partner, Director and Global Leader of Healthcare and
Medical Technologies Practice, Arthur D. Little
-- Eugene Chiu, Co-founder and Vice President Business Development,
Prediction Biosciences
-- Daniel Cole, General Manager, Spray Venture Partners
-- Bob Creeden, Managing Director of the Center for Innovative Ventures,
Partners Healthcare
-- Omid Farokhzad, M.D., Assistant Professor, Harvard Medical School
-- Rainer Fuchs, Executive Director, Biogen Idec Innovation Incubator
(bi3)
-- Michael Greeley, General Partner, IDG Ventures
-- Amar Sawhney, Co-founder, President and CEO, Confluent Surgical
-- Anupendra Sharma, Investment Partner, Siemens Venture Capital
-- Martin Young, Vice President of Corporate Development, Phase Forward
Financial Services Track
-- James Bildner, General Partner, New Horizons
-- Joost Bonsen, Founding Program Director, MIT Legatum Center for
Development and Entrepreneurship
-- Michael Chu, Managing Partner, Ignia Fund
-- Todd Dagres, General Partner, Spark Capital
-- William Foote, President and Founder, Root Capital
-- Bob Higgins, Managing General Partner, Highland Capital Partners
-- Shane Hughes, CEO and President, Pyxis Mobile
-- Anthony Jimenez, President and CEO, MicroTech LLC
-- Stephen Killeen, Carbon Neutral
-- Luda Kopelkina, Founder, Noventra Corporation
-- Michael Lannon, CEO, KoKo Fitness
A closing keynote panel, "Taking New England Global," will focus on how New
England and its institutions supporting innovation can capitalize on its
strengths to continue to build market value. The panel will feature Travis
Bradford, Founder, President and Director of the Prometheus Institute for
Sustainable Development; Elliott Hillback, Executive Vice President of
Corporate Relations, Genzyme; Vinit Nijhawan, Chairman of TIE; and Doug
Solomon, chief technology strategist of IDEO. The panel will be moderated
by Mark Bonchek, CEO of The Truman Company.
For more information on "Power, Drugs and Money," please visit
www.PowerDrugsandMoney.com. This event is expected to sell out quickly and
registration is on a first-come, first-serve basis. Early-bird member
registration is $195 and early-bird non-member registration is $235.
(Early-bird rates are available through January 17.) Walk-in registration
at the conference is $295. The rate for full-time students is $25.
About the MIT Enterprise Forum of Cambridge
The MIT Enterprise Forum of Cambridge is a volunteer, nonprofit
organization based at MIT whose mission is to promote and strengthen the
process of starting and growing innovative science- and technology-oriented
companies by providing services and programs that educate, inform and
support the entrepreneurial community.
Contact Information: MIT ENTERPRISE FORUM OF CAMBRIDGE CONTACT: Trish Fleming MIT Enterprise Forum of Cambridge 617-253-8238 PRESS CONTACT : Barbara Heffner (for MIT Enterprise Forum) CHEN PR, Inc. 781-672-3112